A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer

NCT00036543232 sitesClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study